Search Results - "Boyne, Devon"

BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network Meta-analyses by Béliveau, Audrey, Boyne, Devon J, Slater, Justin, Brenner, Darren, Arora, Paul

“…Several reviews have noted shortcomings regarding the quality and reporting of network meta-analyses (NMAs). We suspect that this issue may be partially…”
Get full text

Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta by Heer, Emily, Ruan, Yibing, Boyne, Devon J, Jarada, Tamer N, Heng, Daniel, Henning, Jan-Willem, Morris, Donald M, O'Sullivan, Dylan E, Cheung, Winson Y, Brenner, Darren R

“…The COVID-19 pandemic is suspected to have affected cancer care and outcomes among patients in Canada. In this study, we evaluated the impact of the state of…”
Get full text

Patient-reported symptom burden and supportive care needs at cancer diagnosis: a retrospective cohort study by Cuthbert, Colleen A., Boyne, Devon J., Yuan, Xu, Hemmelgarn, Brenda R., Cheung, Winson Y.

“…Purpose Patient-reported outcomes (PROs) are used to assess patients’ symptoms and supportive care needs. While PROs are increasingly employed in clinical…”
Get full text

Dose‐response effects of exercise on bone mineral density and content in post‐menopausal women by Gonzalo‐Encabo, Paola, McNeil, Jessica, Boyne, Devon J., Courneya, Kerry S., Friedenreich, Christine M.

“…Exercise is one of the most widely used non‐pharmacological strategies to prevent bone resorption during menopause. Given the detrimental consequences of bone…”
Get full text

Associations between baseline symptom burden as assessed by patient-reported outcomes and overall survival of patients with metastatic cancer by Batra, Atul, Yang, Lin, Boyne, Devon J., Harper, Andrew, Cheung, Winson Y., Cuthbert, Colleen A.

“…Background Serial symptom assessments using patient-reported outcomes may be challenging to implement in routine clinical practices. We aimed to determine if a…”
Get full text

Physical Activity, Global DNA Methylation, and Breast Cancer Risk: A Systematic Literature Review and Meta-analysis by Boyne, Devon J, O'Sullivan, Dylan E, Olij, Branko F, King, Will D, Friedenreich, Christine M, Brenner, Darren R

“…The extent to which physical activity reduces breast cancer risk through changes in global DNA methylation is unknown. We systematically identified studies…”
Get full text

Symptom burden in patients with common cancers near end-of-life and its associations with clinical characteristics: a real-world study by Batra, Atul, Yang, Lin, Boyne, Devon J., Harper, Andrew, Cuthbert, Colleen A., Cheung, Winson Y.

“…Background Patients dying with cancer can experience various physical and psychological symptoms. We aimed to determine the type and severity of symptoms…”
Get full text

Text analysis framework for identifying mutations among non-small cell lung cancer patients from laboratory data by Yusuf, Amman, Boyne, Devon J, O'Sullivan, Dylan E, Brenner, Darren R, Cheung, Winson Y, Mirza, Imran, Jarada, Tamer N

“…Laboratory data can provide great value to support research aimed at reducing the incidence, prolonging survival and enhancing outcomes of cancer. Data is…”
Get full text

Aerobic exercise and DNA methylation in postmenopausal women: An ancillary analysis of the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial by Boyne, Devon J, King, Will D, Brenner, Darren R, McIntyre, John B, Courneya, Kerry S, Friedenreich, Christine M

“…Physical activity is associated with a lower risk of breast, colon, and endometrial cancer. Epigenetic mechanisms such as changes in DNA methylation may help…”
Get full text

Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world data by Boyne, Devon J., Brenner, Darren R., Gupta, Alind, Mackay, Eric, Arora, Paul, Wasiak, Radek, Cheung, Winson Y, Hernán, Miguel A.

“…•FOLFIRINOX and GN are two front-line treatment options for advanced pancreatic cancer.•These treatments have never been compared head-to-head in a randomized…”
Get full text

The efficacy of chemopreventive agents on the incidence of colorectal adenomas: A systematic review and network meta-analysis by Heer, Emily, Ruan, Yibing, Mah, Brittany, Nguyen, Teresa, Lyons, Hannah, Poirier, Abbey, Boyne, Devon J., O'Sullivan, Dylan E., Heitman, Steven J., Hilsden, Robert J., Forbes, Nauzer, Brenner, Darren R.

“…Colorectal cancer (CRC) is the fourth most common cancer and third leading cause of cancer-related death worldwide. Use of chemopreventive agents (CPAs) to…”
Get full text

Real World Evidence Study to Assess Incidence, Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Early-Stage, High-Risk HER2-Negative Breast Cancer in Alberta, Canada by Henning, Jan-Willem, Boyne, Devon J., Brenner, Darren R., Carbonell, Chantelle, Shokar, Simran, Granados, Diana P., Parackal, Anna, Cheung, Winson Y.

“…Data are needed to improve the current understanding of the epidemiology of patients with high-risk, HER2-negative, early breast cancer (eBC) (hormone receptor…”
Get full text

Association Between Endoscopist Annual Procedure Volume and Colonoscopy Quality: Systematic Review and Meta-analysis by Forbes, Nauzer, Boyne, Devon J., Mazurek, Matthew S., Hilsden, Robert J., Sutherland, R. Liam, Pader, Joy, Ruan, Yibing, Shaheen, Abdel Aziz, Wong, Clarence, Lamidi, Mubasiru, Lorenzetti, Diane L., Brenner, Darren R., Heitman, Steven J.

“…In addition to monitoring adverse events (AEs) and post-colonoscopy colorectal cancers (PCCRC), indicators for assessing colonoscopy quality include adenoma…”
Get full text

The Impact of BRAF Mutation Status on Survival Outcomes and Treatment Patterns among Metastatic Colorectal Cancer Patients in Alberta, Canada by Sutherland, R Liam, Boyne, Devon J, Brenner, Darren R, Cheung, Winson Y

“…Colorectal cancer presents via multiple different clinical phenotypes that can arise from a variety of different genetic and molecular alterations. The aim of…”
Get full text

Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors by Stukalin, Igor, Navani, Vishal, Gupta, Mehul, Ruan, Yibing, Boyne, Devon J, O’Sullivan, Dylan E, Meyers, Daniel E, Goutam, Siddhartha, Sander, Michael, Ewanchuk, Benjamin W, Brenner, Darren R, Suo, Aleksi, Cheung, Winson Y, Heng, Daniel Y C, Monzon, Jose G, Cheng, Tina

“…Abstract Background Risk stratification tools for patients with advanced melanoma (AM) treated with immune checkpoint inhibitors (ICI) are lacking. We…”
Get full text

The impact of population-based EGFR testing in non-squamous metastatic non-small cell lung cancer in Alberta, Canada by Brenner, Darren R., O'Sullivan, Dylan E., Jarada, Tamer N., Yusuf, Amman, Boyne, Devon J., Mather, Cheryl A., Box, Adrian, Morris, Donald G., Cheung, Winson Y., Mirza, Imran

“…•We examined outcomes among NSCLC patients for an entire province over twenty years.•>80 % of eligible patients in Alberta who receive care for NSCLC are…”
Get full text

Real-World Study to Assess Patterns of Treatment Practices and Clinical Outcomes in Metastatic Colorectal Cancer Patients with RAS Wild-Type Left-Sided Tumours in Canada by Boyne, Devon J., Ngan, Elaine, Carbonell, Chantelle, Wani, Rajvi J., Cirone Morris, Carlye, Martinez, Daniel Jun, Cheung, Winson Y.

“…Minimal Canadian data are available on the RAS testing rates, treatment patterns, and corresponding overall survival (OS) in metastatic colorectal cancer…”
Get full text

A Real-World Evidence Study Using Alberta-Population-Based Data to Describe Treatment Patterns for Metastatic Castration-Sensitive Prostate Cancer Patients (AWARENESS) by Karim, Safiya, Lowther, Jennifer, Gyulay, Gabriel, O'Sullivan, Dylan, Wallis, Christopher J D, Yip, Steven M, Brenner, Darren R, Boyne, Devon J, Cheung, Winson Y

“…Over the past decade, the treatment of metastatic castration-sensitive prostate cancer (mCSPC) has changed significantly. Current guidelines suggest the use of…”
Get full text

Selection Bias in Real-World Data Studies Used to Support Health Technology Assessments: A Case Study in Metastatic Cancer by Jarada, Tamer N, O'Sullivan, Dylan E, Brenner, Darren R, Cheung, Winson Y, Boyne, Devon J

“…Real-world evidence has been increasingly used to support evaluations of emerging therapies. These investigations are often conducted in settings that may not…”
Get full text

Understanding Characteristics, Treatment Patterns, and Clinical Outcomes for Individuals with Advanced or Recurrent Endometrial Cancer in Alberta, Canada: A Retrospective, Population-Based Cohort Study by Martins, Diana, O'Sullivan, Dylan E, Boyne, Devon J, Cheung, Winson Y, Allonby, Odette, Habash, Mara, Brenner, Darren R, Riemer, Justin, McGee, Jacob

“…Endometrial cancer (EC) incidence has increased in recent decades. However, population-based outcomes data are limited. In this retrospective cohort study, we…”
Get full text